BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 28975435)

  • 1. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.
    Peter RS; Rosenbohm A; Dupuis L; Brehme T; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC
    Eur J Epidemiol; 2017 Oct; 32(10):901-908. PubMed ID: 28975435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis.
    Rosenbohm A; Nagel G; Peter RS; Brehme T; Koenig W; Dupuis L; Rothenbacher D; Ludolph AC;
    JAMA Neurol; 2018 May; 75(5):600-607. PubMed ID: 29482216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value.
    Nagel G; Kurz D; Peter RS; Rosenbohm A; Koenig W; Dupuis L; Bäzner H; Börtlein A; Dempewolf S; Schabet M; Hecht M; Kohler A; Opherk C; Naegele A; Sommer N; Lindner A; Tumani H; Ludolph AC; Rothenbacher D
    Sci Rep; 2023 Nov; 13(1):19594. PubMed ID: 37949878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry.
    Michels S; Kurz D; Rosenbohm A; Peter RS; Just S; Bäzner H; Börtlein A; Dettmers C; Gold HJ; Kohler A; Naumann M; Ratzka P; Ludolph AC; Rothenbacher D; Nagel G; Dorst J;
    J Neurol; 2023 Jun; 270(6):3082-3090. PubMed ID: 36853389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.
    Mariosa D; Beard JD; Umbach DM; Bellocco R; Keller J; Peters TL; Allen KD; Ye W; Sandler DP; Schmidt S; Fang F; Kamel F
    Am J Epidemiol; 2017 Mar; 185(5):362-371. PubMed ID: 28158443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study.
    Shimizu T; Nakayama Y; Matsuda C; Haraguchi M; Bokuda K; Ishikawa-Takata K; Kawata A; Isozaki E
    J Neurol; 2019 Jun; 266(6):1412-1420. PubMed ID: 30868220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population-based registry in southwest Germany.
    Schumacher J; Peter RS; Nagel G; Rothenbacher D; Rosenbohm A; Ludolph AC; Dorst J;
    Eur J Neurol; 2020 Aug; 27(8):1405-1414. PubMed ID: 32396653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia.
    Nagel G; Unal H; Rosenbohm A; Ludolph AC; Rothenbacher D;
    BMC Neurol; 2013 Feb; 13():22. PubMed ID: 23414001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life Course of Physical Activity and Risk and Prognosis of Amyotrophic Lateral Sclerosis in a German ALS Registry.
    Rosenbohm A; Peter R; Dorst J; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC;
    Neurology; 2021 Nov; 97(19):e1955-e1963. PubMed ID: 34670816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia.
    Uenal H; Rosenbohm A; Kufeldt J; Weydt P; Goder K; Ludolph A; Rothenbacher D; Nagel G;
    PLoS One; 2014; 9(4):e93932. PubMed ID: 24722455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany.
    Nagel G; Peter RS; Rosenbohm A; Koenig W; Dupuis L; Rothenbacher D; Ludolph AC
    Sci Rep; 2017 Jun; 7(1):4374. PubMed ID: 28663573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study.
    Westeneng HJ; van Veenhuijzen K; van der Spek RA; Peters S; Visser AE; van Rheenen W; Veldink JH; van den Berg LH
    Lancet Neurol; 2021 May; 20(5):373-384. PubMed ID: 33894192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan.
    Shimizu T; Nagaoka U; Nakayama Y; Kawata A; Kugimoto C; Kuroiwa Y; Kawai M; Shimohata T; Nishizawa M; Mihara B; Arahata H; Fujii N; Namba R; Ito H; Imai T; Nobukuni K; Kondo K; Ogino M; Nakajima T; Komori T
    Amyotroph Lateral Scler; 2012 Jun; 13(4):363-6. PubMed ID: 22632442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis - Results from the ALS Registry Swabia.
    Nagel G; Peter RS; Rosenbohm A; Koenig W; Dupuis L; Rothenbacher D; Ludolph AC
    Sci Rep; 2020 Jan; 10(1):736. PubMed ID: 31959864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles.
    Goutman SA; Boss J; Iyer G; Habra H; Savelieff MG; Karnovsky A; Mukherjee B; Feldman EL
    Muscle Nerve; 2023 Mar; 67(3):208-216. PubMed ID: 36321729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermetabolism in ALS is associated with greater functional decline and shorter survival.
    Steyn FJ; Ioannides ZA; van Eijk RPA; Heggie S; Thorpe KA; Ceslis A; Heshmat S; Henders AK; Wray NR; van den Berg LH; Henderson RD; McCombe PA; Ngo ST
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1016-1023. PubMed ID: 29706605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies.
    O'Reilly ÉJ; Wang M; Adami HO; Alonso A; Bernstein L; van den Brandt P; Buring J; Daugherty S; Deapen D; Freedman DM; English DR; Giles GG; Håkansson N; Kurth T; Schairer C; Weiderpass E; Wolk A; Smith-Warner SA
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):396-406. PubMed ID: 29658324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.
    Rosenbohm A; Liu M; Nagel G; Peter RS; Cui B; Li X; Kassubek J; Rothenbacher D; Lulé D; Cui L; Ludolph AC;
    J Neurol; 2018 Apr; 265(4):774-782. PubMed ID: 29392461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.
    Fasano A; Fini N; Ferraro D; Ferri L; Vinceti M; ; Mandrioli J
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):233-242. PubMed ID: 28076984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
    Chang J; Shaw TB; Holdom CJ; McCombe PA; Henderson RD; Fripp J; Barth M; Guo CC; Ngo ST; Steyn FJ;
    Eur J Neurol; 2023 Jan; 30(1):57-68. PubMed ID: 36214080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.